Liang Wang

5PUBLICATIONS
1CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 22, 2026
Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study with external historical control.

|Jul 30, 2025
Exploration of the Optimal Treatment Modality for Vitreoretinal Lymphoma: A PRISMA Compliant Meta-Analysis and Systematic Review.

Jing Gao, Li-Wei Lv, Jing Yang

|Oct 15, 2024
Evaluating early response assessment in extranodal natural killer/T-cell lymphoma by analyzing ΔSUVlbm between baseline and interim 18F-FDG PET/CT scans.

Lei Yang, Li-Jie Zeng, Shuang Wang

|Jun 09, 2020
New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma.

Liang Wang, Xiao-Qin Chen, Zhong-Jun Xia

|Oct 21, 2018
IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.

Liang Wang, Xi-Wen Bi, Yu-Jia Zhu

Pageof 1

Frequent Collaborators

1 joint publications

Jing Gao